The loss of RUNX1 from intestinal epithelial cells significantly induced tumorigenesis in a conditional knockout mouse model (Fijneman et al., 2012), and the knockdown of RUNX1 in breast cancer cells resulted in hyperproliferation and abnormal morphogenesis (Wang et al., 2011; Janes, 2011). Here, RUNX1 is linked to breast carcinoma.